BIOCRYST PHARMACEUTICALS, INC. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$7.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2021-03-01
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2013-12-31 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2018 was -$7.00K, a 158.33% decline from fiscal 2017.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2017 was $12.00K.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2013 was $47.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|
| 2018-12-31 | -$7.00K 10-K · filed 2021-03-01 | ||
| 2017-12-31 | $12.00K 10-K · filed 2020-03-13 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $47.00K 10-K · filed 2014-03-10 | |
| 2013-09-30 | $47.00K 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |